GDTC peer analysis
CytoMed Therapeutics (GDTC) against its competitors: price, today's move, 1-year return and market value side by side.
- GDTC's peers: CLGN (CollPlant), ENLV (Enlivex), LSTA (Lisata Therapeutics), MTVA (MetaVia), NCNA (NuCana), NRSN (NeuroSense Therapeutics), NRXS (Neuraxis), PASG (Passage Bio).
GDTC and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| CLGN CollPlant | $4.64 | 17.17% | -75.45% | $8.77M |
| ENLV Enlivex | $1.17 | -2.50% | -91.69% | $19.69M |
| LSTA Lisata Therapeutics | $0.91 | -7.15% | -55.17% | $9.83M |
| MTVA MetaVia | $1.07 | 0.94% | -87.27% | $7.21M |
| NCNA NuCana | $0.72 | -13.77% | -78.56% | $4.36M |
| NRSN NeuroSense Therapeutics | $1.26 | -8.03% | -94.22% | $2.39M |
| NRXS Neuraxis | $4.50 | -7.60% | 77.17% | $63.87M |
| PASG Passage Bio | $3.61 | -12.70% | -54.19% | $11.62M |
| XCUR Exicure | $0.98 | -5.77% | -79.32% | $6.42M |
| GDTC CytoMed Therapeutics | $0.77 | -6.87% | -60.56% | $9.15M |